Nuclear _targeted suppression of NF-kappa B activity by the novel quinone derivative E3330
- PMID: 9551916
Nuclear _targeted suppression of NF-kappa B activity by the novel quinone derivative E3330
Abstract
The activation of NF-kappa B consists of at least three steps: degradation of I kappa B alpha, translocation of NF-kappa B into the nucleus, ai post-translational modification of NF-kappa B (e.g., phosphorylation of p65). In the present study, we found that a novel quinone derivative E3330 selectively inhibited NF-kappa B-mediated gene expression without affecting any of these steps. E3330, when included in the culture medium, suppressed NF-kappa B DNA-binding activity in PMA-induced Jurkat cell nuclear extracts, suggesting that the inhibition by E3330 of NF-kappa B-mediated gene expression was due to its ability to suppress NF-kappa B DNA-binding activity. Fractionation of the nuclear extracts by column chromatography revealed that a nuclear factor enhanced NF-kappa B DNA-binding activity and that this enhancing activity was interrupted after treatment with E3330. Moreover, a major polypeptide with a molecular mass of 40 kDa was found to be in the highly purified fraction containing the NF-kappa B-enhancing activity and predominantly bind E3330. Taken together, these results suggest that the NF-kappa B activity, after dissociation from I kappa B, is enhanced by a nuclear factor that is active irrespective of PMA treatment, and the nuclear factor-mediated enhancement is selectively inhibited by E3330. Thus, we conclude that E3330 may belong to a novel class of anti-NF-kappa B drugs.
Similar articles
-
Inhibitory effect of E3330, a novel quinone derivative able to suppress tumor necrosis factor-alpha generation, on activation of nuclear factor-kappa B.Mol Pharmacol. 1996 May;49(5):860-73. Mol Pharmacol. 1996. PMID: 8622636
-
_targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis.Mol Cancer Res. 2008 Jun;6(6):1059-70. doi: 10.1158/1541-7786.MCR-07-2088. Mol Cancer Res. 2008. PMID: 18567808
-
Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.J Immunol. 1999 Dec 15;163(12):6800-9. J Immunol. 1999. PMID: 10586080
-
Regulation of the DNA binding activity of NF-kappa B.Int J Biochem Cell Biol. 1995 Sep;27(9):865-79. doi: 10.1016/1357-2725(95)00071-v. Int J Biochem Cell Biol. 1995. PMID: 7584622 Review.
-
Nuclear factor kappa B activity in response to oxidants and antioxidants.Methods Enzymol. 1999;300:363-74. doi: 10.1016/s0076-6879(99)00141-x. Methods Enzymol. 1999. PMID: 9919537 Review.
Cited by
-
HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b.Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8555-60. doi: 10.1073/pnas.0409863102. Epub 2005 Jun 7. Proc Natl Acad Sci U S A. 2005. PMID: 15941832 Free PMC article.
-
Augmentation of tumor necrosis factor family-induced apoptosis by E3330 in human hepatocellular carcinoma cell lines via inhibition of NF kappa B.World J Gastroenterol. 2005 Oct 28;11(40):6258-61. doi: 10.3748/wjg.v11.i40.6258. World J Gastroenterol. 2005. PMID: 16419152 Free PMC article.
-
Apurinic/apyrimidinic endonuclease 1 alters estrogen receptor activity and estrogen-responsive gene expression.Mol Endocrinol. 2009 Sep;23(9):1346-59. doi: 10.1210/me.2009-0093. Epub 2009 May 21. Mol Endocrinol. 2009. PMID: 19460860 Free PMC article.
-
Identification of JTP-70902, a p15(INK4b)-inductive compound, as a novel MEK1/2 inhibitor.Cancer Sci. 2007 Nov;98(11):1809-16. doi: 10.1111/j.1349-7006.2007.00604.x. Epub 2007 Sep 2. Cancer Sci. 2007. PMID: 17784872 Free PMC article.
-
A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity.Nucleic Acids Res. 2008 Aug;36(13):4327-36. doi: 10.1093/nar/gkn416. Epub 2008 Jun 27. Nucleic Acids Res. 2008. PMID: 18586825 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources